Grant: Discovery Grants Program - Individual
University of Windsor
$33,000.00
Role of platelets in regulating fibrinolysis
FY 2015-16
Summary
Upon injury to a blood vessel, a blood clot forms at the site of injury to prevent catastrophic loss of blood. When repair to the tissue has ensued, the blood clot is removed by a system called the fibrinolytic system. The balance between blood clot formation (coagulation) and blood clot breakdown (fibrinolysis) is crucial, as imbalances can lead to clotting disorders such as heart attacks and strokes or to bleeding disorders such as hemophilia. Our research concerns platelets, which are cell fragments that circulate in the blood and are essential for proper blood clot formation. They are responsible for the first plug at the wound site, and they help to coordinate the blood clotting process. Specifically, we are interesting in the role that platelets play in coordinating the balance between blood clot formation and breakdown. Our current focus is a protein called TAFI (thrombin-activatable fibrinolysis inhibitor) which helps to regulate this balance. It was once thought that TAFI was only present in plasma, which is the fluid portion of blood. However, it appears that there is also a distinct portion of TAFI within the platelet that can be released when platelets become activated at the site of injury. No one knows what the purpose of this platelet form of TAFI is, or if it is different in its properties from plasma TAFI. We propose to answer these questions. First we will try and isolate platelet TAFI in pure form. From there, we can study its characteristics and compare them to those of plasma TAFI. Next, we will assess if platelet TAFI affects the attachment of platelets to injured blood vessel walls and the subsequent formation and breakdown of blood clots. We will do this both in model vessels in test tubes or in mice in which we have specifically deleted either platelet or plasma TAFI. Our studies will provide important new information on how blood clotting and blood clot breakdown are regulated.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
371957-2010
Name nom
Boffa, Michael
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2010
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
5
Nb partie
5
Application title
Role of platelets in regulating fibrinolysis
Keyword
NSERC
Application summary
Upon injury to a blood vessel, a blood clot forms at the site of injury to prevent catastrophic loss of blood. When repair to the tissue has ensued, the blood clot is removed by a system called the fibrinolytic system. The balance between blood clot formation (coagulation) and blood clot breakdown (fibrinolysis) is crucial, as imbalances can lead to clotting disorders such as heart attacks and strokes or to bleeding disorders such as hemophilia. Our research concerns platelets, which are cell fragments that circulate in the blood and are essential for proper blood clot formation. They are responsible for the first plug at the wound site, and they help to coordinate the blood clotting process. Specifically, we are interesting in the role that platelets play in coordinating the balance between blood clot formation and breakdown. Our current focus is a protein called TAFI (thrombin-activatable fibrinolysis inhibitor) which helps to regulate this balance. It was once thought that TAFI was only present in plasma, which is the fluid portion of blood. However, it appears that there is also a distinct portion of TAFI within the platelet that can be released when platelets become activated at the site of injury. No one knows what the purpose of this platelet form of TAFI is, or if it is different in its properties from plasma TAFI. We propose to answer these questions. First we will try and isolate platelet TAFI in pure form. From there, we can study its characteristics and compare them to those of plasma TAFI. Next, we will assess if platelet TAFI affects the attachment of platelets to injured blood vessel walls and the subsequent formation and breakdown of blood clots. We will do this both in model vessels in test tubes or in mice in which we have specifically deleted either platelet or plasma TAFI. Our studies will provide important new information on how blood clotting and blood clot breakdown are regulated.